Xiao-Xiao Wang

501 total citations
11 papers, 321 citations indexed

About

Xiao-Xiao Wang is a scholar working on Pathology and Forensic Medicine, Oncology and Neurology. According to data from OpenAlex, Xiao-Xiao Wang has authored 11 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 6 papers in Oncology and 3 papers in Neurology. Recurrent topics in Xiao-Xiao Wang's work include Lymphoma Diagnosis and Treatment (8 papers), Viral-associated cancers and disorders (4 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). Xiao-Xiao Wang is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Viral-associated cancers and disorders (4 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). Xiao-Xiao Wang collaborates with scholars based in China, United States and Netherlands. Xiao-Xiao Wang's co-authors include Hui-Qiang Huang, Qing-Qing Cai, Ye Zhu, Yao Wu, Qi-Chun Cai, Huali Chen, Meijing Wang, Lu Gan, Wei Jiang and Wen-Qi Jiang and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Carcinogenesis.

In The Last Decade

Xiao-Xiao Wang

11 papers receiving 318 citations

Peers

Xiao-Xiao Wang
Xiao-Xiao Wang
Citations per year, relative to Xiao-Xiao Wang Xiao-Xiao Wang (= 1×) peers Joanna Waligórska‐Stachura

Countries citing papers authored by Xiao-Xiao Wang

Since Specialization
Citations

This map shows the geographic impact of Xiao-Xiao Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao-Xiao Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao-Xiao Wang more than expected).

Fields of papers citing papers by Xiao-Xiao Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao-Xiao Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao-Xiao Wang. The network helps show where Xiao-Xiao Wang may publish in the future.

Co-authorship network of co-authors of Xiao-Xiao Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao-Xiao Wang. A scholar is included among the top collaborators of Xiao-Xiao Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao-Xiao Wang. Xiao-Xiao Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Wang, Xiao-Xiao, Pengfei Li, Bing Bai, et al.. (2019). Differential clinical significance of pre-, interim-, and post-treatment plasma Epstein–Barr virus DNA load in NK/T-cell lymphoma treated with P-GEMOX protocol. Leukemia & lymphoma. 60(8). 1917–1925. 13 indexed citations
2.
Winde, Charlotte M. de, Sharon Veenbergen, Ken H. Young, et al.. (2016). Tetraspanin CD37 protects against the development of B cell lymphoma. Journal of Clinical Investigation. 126(2). 653–666. 41 indexed citations
3.
Wang, Xiao-Xiao, Lu Gan, Huali Chen, et al.. (2016). SIRT6 protects cardiomyocytes against ischemia/reperfusion injury by augmenting FoxO3α-dependent antioxidant defense mechanisms. Basic Research in Cardiology. 111(2). 13–13. 134 indexed citations
4.
Yan, Zheng, Hui-Qiang Huang, Xiao-Xiao Wang, et al.. (2015). A TNM Staging System for Nasal NK/T-Cell Lymphoma. PLoS ONE. 10(6). e0130984–e0130984. 17 indexed citations
5.
Zhao, Wei, Bin Bai, Qi-Chun Cai, et al.. (2014). Safety and efficacy of non-initial rapid infusion of rituximab plus chemotherapy in Chinese patients with CD20+non-Hodgkin’s lymphoma. Expert Opinion on Drug Safety. 14(1). 21–29. 2 indexed citations
9.
Bai, Bing, Hui-Qiang Huang, Qi-Chun Cai, et al.. (2013). Predictive value of pretreatment positron emission tomography/computed tomography in patients with newly diagnosed extranodal natural killer/T-cell lymphoma. Medical Oncology. 30(1). 339–339. 17 indexed citations
10.
Bai, Bing, Qi-Chun Cai, Qing-Qing Cai, et al.. (2012). High numbers of tumor-associated macrophages correlate with poor prognosis in patients with mature T- and natural killer cell lymphomas. Medical Oncology. 29(5). 3522–3528. 26 indexed citations
11.
Wang, Xiao-Xiao, Xiaochao Chen, Jianhua Chang, et al.. (2007). BCRP gene polymorphisms are associated with susceptibility and survival of diffuse large B-cell lymphoma. Carcinogenesis. 28(8). 1740–1744. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026